In today’s briefing:
- Analog Devices: The Less Attention It Gets The Better
- B2B Life Sciences Marketplace Labviva Secures US$20M Series A
- CFTC V. Binance: The Data Behind the Suit
Analog Devices: The Less Attention It Gets The Better
- Analog Devices has become one of the best-performing semiconductors stocks.
- The company’s strategy has certain weaknesses, but ADI remains among my top picks within the sector.
- ADI’s performance is not just a fluke and there are solid reasons behind it, such as high profitability, growth and competitive positioning.
B2B Life Sciences Marketplace Labviva Secures US$20M Series A
- Labviva, a Singapore- and US-based AI-driven life sciences digital marketplace, has secured US$20 million in Series A financing led by Biospring Partners.
- Existing investors Senator Investment Group, B Capital, and Glasswing Ventures co-invested.
- The Series A funding brings the total amount raised since inception to US$30 million.
CFTC V. Binance: The Data Behind the Suit
- Binance is the world’s largest crypto exchange by a huge margin.
- It has achieved consistent growth since its founding in 2017, but its increasing dominance has been striking to watch since 2020, when it held around 25% of spot volume market share.
- Its market share approached 50% at the tail end of the 2021 bull market before retreating and again expanding to peak over 70% this year.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Data and News
- ✓ Events & Webinars
